ABSTRACT
PURPOSE: The state of limited resource settings that Coronavirus (COVID-19) pandemic has created globally should be taken seriously into account especially in healthcare sector. In oncofertility, patients should receive their fertility preservation treatments urgently even in limited resource settings before initiation of anticancer therapy. Therefore, it is very crucial to learn more about oncofertility practice in limited resource settings such as in developing countries that suffer often from shortage of healthcare services provided to young patients with cancer. METHODS: As an extrapolation during the global crisis of COVID-19 pandemic, we surveyed oncofertility centers from 14 developing countries (Egypt, Tunisia, Brazil, Peru, Panama, Mexico, Colombia, Guatemala, Argentina, Chile, Nigeria, South Africa, Saudi Arabia, and India). Survey questionnaire included questions on the availability and degree of utilization of fertility preservation options in case of childhood cancer, breast cancer, and blood cancer. RESULTS: All surveyed centers responded to all questions. Responses and their calculated oncofertility scores showed different domestic standards for oncofertility practice in case of childhood cancer, breast cancer, and blood cancer in the developing countries under limited resource settings. CONCLUSIONS: Medical practice in limited resource settings has become a critical topic especially after the global crisis of COVID-19 pandemic. Understanding the resources necessary to provide oncofertility treatments is important until the current COVID-19 pandemic resolves. Lessons learned will be valuable to future potential worldwide disruptions due to infectious diseases or other global crises.
Subject(s)
Betacoronavirus/pathogenicity , Coronavirus Infections/prevention & control , Delivery of Health Care/standards , Fertility Preservation/methods , Neoplasms/therapy , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/transmission , Coronavirus Infections/virology , Delivery of Health Care/economics , Developing Countries , Female , Fertility Preservation/economics , Fertility Preservation/statistics & numerical data , Humans , Neoplasms/virology , Pneumonia, Viral/transmission , Pneumonia, Viral/virology , SARS-CoV-2 , Surveys and QuestionnairesSubject(s)
Humans , Comparative Study , Female , Pregnancy , Endometriosis/therapy , Infertility, Female/therapy , Bronchoscopy/statistics & numerical data , Laparotomy/statistics & numerical data , Recurrence , Tissue Adhesions/surgery , Tissue Adhesions/therapy , Endometriosis/diagnostic imaging , Prospective StudiesSubject(s)
Humans , Female , Male , Adult , Insemination, Artificial/methods , Embryo Transfer/methods , Fertilization in Vitro/methodsSubject(s)
Humans , Female , Male , Adult , Fertilization in Vitro/methods , Insemination, Artificial/methods , Embryo Transfer/methodsABSTRACT
El potencial reproductivo de la mujer, desciende con la edad y las diferentes técnicas de Fertilización Asistida no han conseguido variar este hecho. En el presente trabajo analizamos los parámetros de respuesta a nivel ovárico, nº de folículos, promedio de estradiol plasmático, nº de ovocitos maduros, promedio de ampollas utilizadas, embarazos y evolución de los mismos, sobre 472 ciclos de GIFT, dividiendo a las pacientes en menores y mayores de 37 años, observando diferencias alt
Subject(s)
Humans , Comparative Study , Female , Pregnancy , Adult , Middle Aged , Fertilization in Vitro/statistics & numerical data , Age Factors , Pregnancy/statistics & numerical dataABSTRACT
El potencial reproductivo de la mujer, desciende con la edad y las diferentes técnicas de Fertilización Asistida no han conseguido variar este hecho. En el presente trabajo analizamos los parámetros de respuesta a nivel ovárico, nº de folículos, promedio de estradiol plasmático, nº de ovocitos maduros, promedio de ampollas utilizadas, embarazos y evolución de los mismos, sobre 472 ciclos de GIFT, dividiendo a las pacientes en menores y mayores de 37 años, observando diferencias altamente significativas en todos ellos. Se excluyeron del material los procedimientos realizados por factor masculino, con el objeto de homogeneizar la población y poder estudiar así las respuestas a nivel femenino. No encontramos un esquema de inducción que fuera superior en el logro del embarazo en el grupo de pacientes mayores. Los resultados en cuanto a THBR fueron significativamente mayores en el grupo de pacientes más jovenes (24,66 por ciento vs 10,25 por ciento), mientras que los abortos muestran una tendencia superior en las pacientes de 37 años
